The Illinois Patient Experience Study

Written By Carmen Brace

Aclara Research conducted the first study of Illinois patients since the inception of the medical cannabis pilot program. This study of nearly 300 respondents was the first, largest and most comprehensive study of the impact of medical cannabis on patient health and well-being within the market. This 74 question survey focused on the leading conditions and symptoms, product segment and brand purchases, perceived product efficacy and experience within the health care system.

Click here to read press the press release.

Carmen Brace

Carmen Brace is a foresight and emerging trends expert with vast experience at the intersection of cannabis, wellness and the consumer-packaged goods industry. She identified cannabis as a disruptor to consumer health and wellness behavior in 2016 after a career leading insights and strategy at leading CPG companies.

Her futurist mindset and pioneer work ethic led her to launch Aclara Research, a cannabis insights and consulting firm with clients in CPG and cannabis.

She is an advisory member of the Illinois Governor’s Committee on Cannabis and Health, is an expert witness for the Illinois legislature and a featured speaker across many of the industry’s top conferences.

Previous

Aclara Research Leads Medical Cannabis Industry with Release of Largest Illinois Patient Study